Aspira Women's Health Inc. (AWH)
USD 0.77
(1.97%)
USD 0.77
(1.97%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.26 Million USD | 21.83% |
| 2022 | 4.31 Million USD | 41.05% |
| 2021 | 3.06 Million USD | 147.73% |
| 2020 | 1.23 Million USD | 3.43% |
| 2019 | 1.19 Million USD | 1442.7% |
| 2018 | -89 Thousand USD | -143.0% |
| 2017 | 207 Thousand USD | 469.64% |
| 2016 | -56 Thousand USD | 57.58% |
| 2015 | -132 Thousand USD | -110.22% |
| 2014 | 1.29 Million USD | -46.12% |
| 2013 | 2.39 Million USD | 22.06% |
| 2012 | 1.96 Million USD | 9.42% |
| 2011 | 1.79 Million USD | 65.04% |
| 2010 | 1.08 Million USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 100 Thousand USD | 525.0% |
| 2007 | 16 Thousand USD | -99.82% |
| 2006 | 8.87 Million USD | -34.5% |
| 2005 | 13.55 Million USD | -46.02% |
| 2004 | 25.1 Million USD | -17.76% |
| 2003 | 30.52 Million USD | 15.01% |
| 2002 | 26.54 Million USD | 113.45% |
| 2001 | 12.43 Million USD | -21.04% |
| 2000 | 15.74 Million USD | 200.25% |
| 1999 | 5.24 Million USD | 181.23% |
| 1998 | 1.86 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.42 Million USD | 17.05% |
| 2024 Q1 | 1.21 Million USD | -0.41% |
| 2023 Q3 | 1.3 Million USD | -15.68% |
| 2023 Q1 | 1.19 Million USD | -3.64% |
| 2023 FY | 5.26 Million USD | 21.83% |
| 2023 Q2 | 1.55 Million USD | 30.14% |
| 2023 Q4 | 1.21 Million USD | -6.73% |
| 2022 Q3 | 1.15 Million USD | 19.67% |
| 2022 Q2 | 966 Thousand USD | 0.52% |
| 2022 Q1 | 961 Thousand USD | -5.23% |
| 2022 FY | 4.31 Million USD | 41.05% |
| 2022 Q4 | 1.23 Million USD | 6.92% |
| 2021 Q3 | 749 Thousand USD | 7.61% |
| 2021 Q1 | 603 Thousand USD | 161.04% |
| 2021 Q4 | 1.01 Million USD | 35.38% |
| 2021 Q2 | 696 Thousand USD | 15.42% |
| 2021 FY | 3.06 Million USD | 147.73% |
| 2020 Q3 | 432 Thousand USD | 182.35% |
| 2020 Q2 | 153 Thousand USD | -63.57% |
| 2020 FY | 1.23 Million USD | 3.43% |
| 2020 Q1 | 420 Thousand USD | -18.6% |
| 2020 Q4 | 231 Thousand USD | -46.53% |
| 2019 Q3 | 336 Thousand USD | 43.59% |
| 2019 FY | 1.19 Million USD | 1442.7% |
| 2019 Q2 | 234 Thousand USD | 114.68% |
| 2019 Q1 | 109 Thousand USD | -35.5% |
| 2019 Q4 | 516 Thousand USD | 53.57% |
| 2018 Q3 | -4000.00 USD | 96.0% |
| 2018 Q4 | 169 Thousand USD | 4325.0% |
| 2018 FY | -89 Thousand USD | -143.0% |
| 2018 Q1 | -154 Thousand USD | -283.33% |
| 2018 Q2 | -100 Thousand USD | 35.06% |
| 2017 Q3 | -80 Thousand USD | -139.22% |
| 2017 Q2 | 204 Thousand USD | 20500.0% |
| 2017 Q1 | -1000.00 USD | -102.56% |
| 2017 FY | 207 Thousand USD | 469.64% |
| 2017 Q4 | 84 Thousand USD | 205.0% |
| 2016 Q3 | -194 Thousand USD | -259.02% |
| 2016 Q1 | -23 Thousand USD | 81.75% |
| 2016 Q2 | 122 Thousand USD | 630.43% |
| 2016 Q4 | 39 Thousand USD | 120.1% |
| 2016 FY | -56 Thousand USD | 57.58% |
| 2015 FY | -132 Thousand USD | -110.22% |
| 2015 Q4 | -126 Thousand USD | 70.49% |
| 2015 Q3 | -427 Thousand USD | -994.87% |
| 2015 Q2 | -39 Thousand USD | -108.48% |
| 2015 Q1 | 460 Thousand USD | -57.72% |
| 2014 Q2 | 236 Thousand USD | -5.6% |
| 2014 Q3 | -283 Thousand USD | -219.92% |
| 2014 FY | 1.29 Million USD | -46.12% |
| 2014 Q4 | 1.08 Million USD | 484.45% |
| 2014 Q1 | 250 Thousand USD | -83.45% |
| 2013 Q1 | 291 Thousand USD | -73.78% |
| 2013 Q3 | 305 Thousand USD | 5.54% |
| 2013 Q2 | 289 Thousand USD | -0.69% |
| 2013 Q4 | 1.51 Million USD | 395.41% |
| 2013 FY | 2.39 Million USD | 22.06% |
| 2012 Q4 | 1.11 Million USD | 288.11% |
| 2012 Q2 | 293 Thousand USD | 6.93% |
| 2012 FY | 1.96 Million USD | 9.42% |
| 2012 Q1 | 274 Thousand USD | -67.54% |
| 2012 Q3 | 286 Thousand USD | -2.39% |
| 2011 Q4 | 844 Thousand USD | 187.07% |
| 2011 Q1 | 389 Thousand USD | 37.94% |
| 2011 Q3 | 294 Thousand USD | 10.11% |
| 2011 Q2 | 267 Thousand USD | -31.36% |
| 2011 FY | 1.79 Million USD | 65.04% |
| 2010 Q4 | 282 Thousand USD | -29.5% |
| 2010 Q3 | 400 Thousand USD | 20.48% |
| 2010 Q2 | 332 Thousand USD | 354.79% |
| 2010 Q1 | 73 Thousand USD | 0.0% |
| 2010 FY | 1.08 Million USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q1 | 31 Thousand USD | 210.0% |
| 2008 FY | 100 Thousand USD | 525.0% |
| 2008 Q2 | - USD | -100.0% |
| 2008 Q3 | 69 Thousand USD | 0.0% |
| 2008 Q4 | - USD | -100.0% |
| 2007 Q2 | - USD | -100.0% |
| 2007 Q1 | 6000.00 USD | -99.15% |
| 2007 FY | 16 Thousand USD | -99.82% |
| 2007 Q4 | 10 Thousand USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q2 | 2.32 Million USD | -36.48% |
| 2006 Q1 | 3.66 Million USD | 23.03% |
| 2006 Q3 | 2.18 Million USD | -6.15% |
| 2006 Q4 | 710 Thousand USD | -67.46% |
| 2006 FY | 8.87 Million USD | -34.5% |
| 2005 FY | 13.55 Million USD | -46.02% |
| 2005 Q1 | 3.51 Million USD | 90.72% |
| 2005 Q3 | 3.7 Million USD | -0.08% |
| 2005 Q4 | 2.97 Million USD | -19.75% |
| 2005 Q2 | 3.71 Million USD | 5.61% |
| 2004 Q2 | 5.48 Million USD | -48.31% |
| 2004 Q1 | 10.6 Million USD | 7.31% |
| 2004 Q3 | 7.17 Million USD | 30.84% |
| 2004 FY | 25.1 Million USD | -17.76% |
| 2004 Q4 | 1.84 Million USD | -74.32% |
| 2003 Q2 | 2.3 Million USD | -71.29% |
| 2003 Q4 | 9.88 Million USD | -4.25% |
| 2003 Q1 | 8.01 Million USD | -17.48% |
| 2003 Q3 | 10.32 Million USD | 348.44% |
| 2003 FY | 30.52 Million USD | 15.01% |
| 2002 Q3 | 6.7 Million USD | 15.57% |
| 2002 Q4 | 9.71 Million USD | 44.82% |
| 2002 FY | 26.54 Million USD | 113.45% |
| 2002 Q1 | 4.31 Million USD | -7.51% |
| 2002 Q2 | 5.8 Million USD | 34.62% |
| 2001 Q1 | 1.68 Million USD | -62.52% |
| 2001 FY | 12.43 Million USD | -21.04% |
| 2001 Q4 | 4.66 Million USD | 34.97% |
| 2001 Q3 | 3.45 Million USD | 31.03% |
| 2001 Q2 | 2.63 Million USD | 56.63% |
| 2000 Q1 | 1.82 Million USD | 0.0% |
| 2000 Q2 | 1.82 Million USD | 0.05% |
| 2000 Q4 | 4.49 Million USD | 264.74% |
| 2000 Q3 | 1.23 Million USD | -32.4% |
| 2000 FY | 15.74 Million USD | 200.25% |
| 1999 FY | 5.24 Million USD | 181.23% |
| 1998 FY | 1.86 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | 44.993% |
| Prenetics Global Limited | 8.82 Million USD | 40.407% |
| Star Equity Holdings, Inc. | 11.92 Million USD | 55.878% |
| CareDx, Inc | 178.32 Million USD | 97.049% |
| Exact Sciences Corporation | 1.84 Billion USD | 99.715% |
| Exagen Inc. | 29.45 Million USD | 82.136% |
| Inotiv, Inc. | 165.44 Million USD | 96.819% |
| Guardant Health, Inc. | 336.89 Million USD | 98.438% |
| Biodesix, Inc. | 36.07 Million USD | 85.415% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -295.788% |
| Precipio, Inc. | 6.01 Million USD | 12.562% |
| iSpecimen Inc. | 5.1 Million USD | -3.017% |
| Natera, Inc. | 492.74 Million USD | 98.932% |
| Standard BioTools Inc. | 50.45 Million USD | 89.57% |
| 23andMe Holding Co. | 99.37 Million USD | 94.705% |
| Castle Biosciences, Inc. | 174.8 Million USD | 96.99% |
| Personalis, Inc. | 18.2 Million USD | 71.101% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | 60.039% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | 4.905% |
| OpGen, Inc. | -90.69 Thousand USD | 5901.927% |
| T2 Biosystems, Inc. | -8.17 Million USD | 164.406% |
| Myriad Genetics, Inc. | 476.4 Million USD | 98.895% |
| ICON Public Limited Company | 1.81 Billion USD | 99.71% |
| NeoGenomics, Inc. | 244.6 Million USD | 97.849% |
| Star Equity Holdings, Inc. | 11.92 Million USD | 55.878% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 99.76% |
| RadNet, Inc. | 93 Million USD | 94.342% |
| MDxHealth SA | 43.92 Million USD | 88.022% |
| Psychemedics Corporation | 8.41 Million USD | 37.454% |
| Illumina, Inc. | 2.74 Billion USD | 99.808% |
| Check-Cap Ltd. | -212 Thousand USD | 2582.075% |
| Twist Bioscience Corporation | 133.34 Million USD | 96.054% |
| DarioHealth Corp. | 5.98 Million USD | 12.066% |
| Fulgent Genetics, Inc. | 104.45 Million USD | 94.962% |
| Sera Prognostics, Inc. | 96 Thousand USD | -5381.25% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 2010.322% |
| OPKO Health, Inc. | 318.12 Million USD | 98.346% |
| Medpace Holdings, Inc. | 524.5 Million USD | 98.997% |
| Neogen Corporation | 463.9 Million USD | 98.866% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -269.101% |
| Prenetics Global Limited | 8.82 Million USD | 40.407% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -932.455% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -564.717% |
| Trinity Biotech plc | 19.45 Million USD | 72.946% |
| Neuronetics, Inc. | 51.7 Million USD | 89.823% |
| Sotera Health Company | 577.15 Million USD | 99.088% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -564.717% |